amrinone has been researched along with Cardiovascular Pregnancy Complications in 1 studies
Amrinone: A positive inotropic cardiotonic (CARDIOTONIC AGENTS) with vasodilator properties, phosphodiesterase 3 inhibitory activity, and the ability to stimulate calcium ion influx into the cardiac cell.
amrinone : A 3,4'-bipyridine substituted at positions 5 and 6 by an amino group and a keto function respectively. A pyridine phosphodiesterase 3 inhibitor, it is a drug that may improve the prognosis in patients with congestive heart failure.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The use of amrinone, a cardiac inotropic agent with vasodilatory properties, has not been described in human pregnancy." | 7.68 | Use of intravenous amrinone in the short-term management of refractory heart failure in pregnancy. ( Bhatia, RK; Ganguly, S; Jelsema, RD, 1991) |
| "The use of amrinone, a cardiac inotropic agent with vasodilatory properties, has not been described in human pregnancy." | 3.68 | Use of intravenous amrinone in the short-term management of refractory heart failure in pregnancy. ( Bhatia, RK; Ganguly, S; Jelsema, RD, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jelsema, RD | 1 |
| Bhatia, RK | 1 |
| Ganguly, S | 1 |
1 other study available for amrinone and Cardiovascular Pregnancy Complications
| Article | Year |
|---|---|
Use of intravenous amrinone in the short-term management of refractory heart failure in pregnancy.
Topics: Acidosis, Lactic; Adult; Amrinone; Arrhythmias, Cardiac; Endocarditis, Bacterial; Female; Heart Fail | 1991 |